Available worldwide via Amazon (Kindle Edition)
US: $5.99
Other regions: Local Amazon pricing
Available here:
https://www.amazon.nl/dp/B0GMXLX56T
Europe has long excelled at generating innovation. The next challenge is ensuring that Europe’s most promising companies can also scale, remain anchored and create long-term value through a stronger architecture of patient growth capital.
Europe has no shortage of innovation. The greater question is who ultimately owns the companies that transform scientific breakthroughs into industrial power. Ownership is no longer simply a financial issue. It increasingly determines where decisions are made, where ecosystems grow and where Europe’s future competitiveness takes shape.
Europe has never lacked innovation. Its challenge has been transforming research excellence into global companies that remain rooted in Europe. The scale-up gap raises a deeper question: can Europe build the capital architecture needed to turn innovation into ownership, influence and long-term sovereignty?
Europe has long excelled at generating knowledge, innovation and entrepreneurship. Retaining ownership and long-term value creation has proven more difficult. Emerging growth initiatives suggest that Europe may finally be learning not only how to innovate, but also how to finance its own future.
